| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86581 |
Ho-p-SCN-Bn-DOTA；2126179-28-8 |
104 |
wyh |
2024-11-22 |
| 86582 |
3-碘-2-丙炔基丁基氨基甲酸丁酯 |
84 |
WYQ |
2024-11-22 |
| 86583 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-环糊精 |
82 |
WYQ |
2024-11-22 |
| 86584 |
DOTA-三(酸) - 酰胺-DPEG(R)24-酰氨基-DPEG(R)24-DSPE |
84 |
zyl |
2024-11-22 |
| 86585 |
N-[4-氯-2-氯-2-氟-5-[1-甲基2-丙炔基)氧]苯基]-3,4,5,6-四氢酞酰亚胺 |
118 |
WYQ |
2024-11-22 |
| 86586 |
磷脂-DOTA大环配体及其衍生物，DOTA-DSPE/DOTA-DPG |
124 |
kx |
2024-11-22 |
| 86587 |
Ho-p-SCN-Bn-DOTA；2126179-28-8 |
80 |
wyh |
2024-11-22 |
| 86588 |
DOTA-C-糖基双功能螯合剂 DOTA-C-glyco-c(RGDfC) |
90 |
zcy |
2024-11-22 |
| 86589 |
BCN-PEG-DOTA |
80 |
kx |
2024-11-22 |
| 86590 |
DOTA-SST DOTA结合的生长抑素受体靶向肽SST |
115 |
zcy |
2024-11-22 |
| 86591 |
DOTA-ADIBO |
124 |
wyh |
2024-11-22 |
| 86592 |
177943-89-4,DOTA和奥曲肽偶联双功能螯合配体 |
94 |
kx |
2024-11-22 |
| 86593 |
DOTA-TRIS(TBE) - 酰胺基DPEG(R)11-马来酰亚胺 |
104 |
zyl |
2024-11-22 |
| 86594 |
DOTA-Ala-Ala-COOH ； DOTA-丙氨酸-丙氨酸-羧酸 |
102 |
wyh |
2024-11-22 |
| 86595 |
DOTA(Gd)-ANADYWR 整合素α6靶向磁共振(MR)探针 |
104 |
zcy |
2024-11-22 |
| 86596 |
181065-46-3,p-NH2-Bn-DOTA |
84 |
kx |
2024-11-22 |
| 86597 |
CAS：177943-89-4 DOTATATE acetate |
99 |
zyl |
2024-11-22 |
| 86598 |
Dota-Eb-Tate DOTA标记生长抑素类似物 |
89 |
zcy |
2024-11-22 |
| 86599 |
DOTA-tri-t-Bu-ester，DOTA-tris(t-Bu ester)；DOTA-三叔丁酯 |
110 |
wyh |
2024-11-22 |
| 86600 |
817562-90-6,(R)-tert-Bu4-DOTAGA,(R)-DOTAGA-四叔丁酯 |
91 |
kx |
2024-11-22 |
| 86601 |
CAS：137076-54-1 三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
98 |
zyl |
2024-11-22 |
| 86602 |
3-碘-2-丙炔基丁基氨基甲酸丁酯 |
77 |
WYQ |
2024-11-22 |
| 86603 |
HPPH-17偶联水溶性Gd(III)-氨乙基酰胺基-DOTA |
112 |
zcy |
2024-11-22 |
| 86604 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-环糊精 |
100 |
WYQ |
2024-11-22 |
| 86605 |
DOTA-CH2-Ph-azide(HCl salt) |
72 |
wyh |
2024-11-22 |
| 86606 |
204318-14-9,Edotreotide ,DOTA-TOC,DOTA-(酪氨酸3)-奥曲肽 |
98 |
kx |
2024-11-22 |
| 86607 |
CAS：911197-00-7 Propargyl-DOTA-tris(tBu)ester |
99 |
zyl |
2024-11-22 |
| 86608 |
罗丹明B,1-O-丙炔基-2,3,4,6-四-O-乙酰基-β-D-葡萄糖苷 |
113 |
WYQ |
2024-11-22 |
| 86609 |
DOTA-UAMC1110 DOTA螯合剂偶联FAP抑制剂(UAMC1110) |
139 |
zcy |
2024-11-22 |
| 86610 |
1-(1,3-二苯基-2-丙炔基)-哌啶 |
103 |
WYQ |
2024-11-22 |
| 86611 |
p-SCN-Bn-DOTA；127985-74-4 |
91 |
wyh |
2024-11-22 |
| 86612 |
(S)-5-氯-α-环丙炔基-2-氨基-α-三氟甲基苯甲醇 |
129 |
WYQ |
2024-11-22 |
| 86613 |
DOTA-NHS ester,四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
103 |
kx |
2024-11-22 |
| 86614 |
cas:149819-85-2 Iron DOTA Sodium Salt |
95 |
zyl |
2024-11-22 |
| 86615 |
Maleimide-DOTA ；1006711-90-5 |
99 |
wyh |
2024-11-22 |
| 86616 |
Cy3标记的血清聚糖 齐岳定制 |
84 |
zcy |
2024-11-22 |
| 86617 |
DOTA-tris (t-Bu ester) |
109 |
kx |
2024-11-22 |
| 86618 |
Dota-Eb-Tate Dota偶联生长抑素类似物 |
119 |
zcy |
2024-11-22 |
| 86619 |
2-Aminoethyl-mono-amide-DOTA-tris(tBu ester) ；173308-19-5 |
98 |
wyh |
2024-11-22 |
| 86620 |
DOTA-TRI(ACID)-酰胺-三聚乙二醇-溴乙酰胺 |
94 |
zyl |
2024-11-22 |
| 86621 |
DOTA mono-NHS ester |
104 |
kx |
2024-11-22 |
| 86622 |
DOTA-Peptide 2 DOTA螯合多肽 |
97 |
zcy |
2024-11-22 |
| 86623 |
DOTA-peg-TAT ；大环配体-聚乙二醇- 穿膜肽 |
98 |
wyh |
2024-11-22 |
| 86624 |
cas:250612-06-7 DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2 |
119 |
wyh |
2024-11-22 |
| 86625 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2 |
121 |
kx |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询